GRNVAC1

GRNVAC1 · Asterias Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GRNVAC1, covering 2019-07-09 to 2019-07-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML) [Phase 2]